Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.

[1]  G. Marenzi,et al.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.

[2]  G. Stone,et al.  Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarction. , 2003, The American journal of cardiology.

[3]  M. Lauer,et al.  Frequent ventricular ectopy after exercise as a predictor of death. , 2003, The New England journal of medicine.

[4]  Sven-Göran Fransson,et al.  Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[5]  Chi‐Hang Lee,et al.  Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. , 2003, JAMA.

[6]  G. Stone,et al.  Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. , 2002, The Journal of invasive cardiology.

[7]  Rosario V. Freeman,et al.  Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. , 2002, The American journal of cardiology.

[8]  A. Jaffe,et al.  Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.

[9]  M. Mcclellan,et al.  Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.

[10]  R. Califf,et al.  Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes , 2002, Circulation.

[11]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[12]  M. Bell,et al.  The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. , 2002, Journal of the American College of Cardiology.

[13]  William S Weintraub,et al.  Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. , 2002, Journal of the American College of Cardiology.

[14]  S. Yusuf,et al.  Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.

[15]  J. Kopple,et al.  National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  I. Palacios,et al.  Are Patients With Renal Failure Good Candidates for Percutaneous Coronary Revascularization in the New Device Era? , 2000, Circulation.

[17]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.

[18]  C B Granger,et al.  Risk stratification and therapeutic decision making in acute coronary syndromes. , 2000, JAMA.

[19]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[20]  G. Helft,et al.  Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. , 2000, The American journal of cardiology.

[21]  W. O’Neill,et al.  A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study , 1999 .

[22]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[23]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[24]  K. Browne,et al.  Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. , 1996, American heart journal.

[25]  C. Viscoli,et al.  The effect of acute renal failure on mortality. A cohort analysis. , 1996, JAMA.

[26]  Y. Wang,et al.  Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. , 1990, The American journal of medicine.

[27]  M. Hlatky,et al.  Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. , 1989, Annals of internal medicine.

[28]  L. Fisher,et al.  Risks for renal dysfunction with cardiac angiography. , 1986, Annals of internal medicine.

[29]  D. Roe,et al.  Predicting angiography-induced acute renal function impairment: clinical risk model. , 1983, AJR. American journal of roentgenology.

[30]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .